BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹24 Cr | ₹2.78 Cr | ₹3.66 Cr | ₹0.04 Cr | ₹0.01 Cr |
What is the latest Total Non-Current Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹2.78 Cr |
| Mar2023 | ₹3.66 Cr |
| Mar2022 | ₹0.04 Cr |
| Mar2021 | ₹0.01 Cr |
How is Total Non-Current Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | 765.35 | |
| Mar2024 | ₹2.78 Cr | -23.91 | |
| Mar2023 | ₹3.66 Cr | 9,274.36 | |
| Mar2022 | ₹0.04 Cr | 457.14 | |
| Mar2021 | ₹0.01 Cr | - | |
Compare Total Non-Current Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹113.5 Cr | -5.9% | -12.1% | -66.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹278,657.0 Cr | 0.7% | 6% | 1.6% | Stock Analytics | |
| REDINGTON | ₹19,927.4 Cr | -3.1% | -3.8% | 5.8% | Stock Analytics | |
| HONASA CONSUMER | ₹9,954.7 Cr | 1.5% | 12.2% | 31% | Stock Analytics | |
| MMTC | ₹9,414.0 Cr | -1.8% | -4.9% | 3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,417.4 Cr | -0.3% | 0.8% | 27.9% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.9% |
-12.1% |
-66.5% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses